Evidence map›Paper›PMID 40104729›Full record

ArticleTranslational cancer research2025

Specific effects of hypoxia-immune core gene

Kang Sun, Luyao Wang, Xueying Zhang, Huili Chen, Ziqiang Wang, Jing Zhang, Xiaojing Wang, Chaoqun Lian

Abstract read
In one paragraph

Article in Translational cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kang SunAnhui Province Key Laboratory of Respiratory Tumor and Infectious Disease, Department of Pulmonary and Critical Care Medicine, Molecular Diagnosis Center, First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Luyao WangDepartment of Genetics, School of Life Sciences, Bengbu Medical University, Bengbu, China.
Xueying ZhangAnhui Province Key Laboratory of Respiratory Tumor and Infectious Disease, Department of Pulmonary and Critical Care Medicine, Molecular Diagnosis Center, First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Huili ChenResearch Center of Clinical Laboratory Science, Bengbu Medical University, Bengbu, China.
Ziqiang WangResearch Center of Clinical Laboratory Science, Bengbu Medical University, Bengbu, China.
Jing ZhangDepartment of Genetics, School of Life Sciences, Bengbu Medical University, Bengbu, China.
Xiaojing WangAnhui Province Key Laboratory of Respiratory Tumor and Infectious Disease, Department of Pulmonary and Critical Care Medicine, Molecular Diagnosis Center, First Affiliated Hospital of Bengbu Medical University, Bengbu, China.
Chaoqun LianResearch Center of Clinical Laboratory Science, Bengbu Medical University, Bengbu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The changes in tumor microenvironment (TME) are closely related to the regulation of immunity and hypoxia. This study aimed to investigate the specific effects of Methods: The core gene Results: Conclusions: The expression of

Indexed as

ARHGAP11Ahypoxiaimmune microenvironmentLung adenocarcinoma (LUAD)prognosis

Identifiers

PMID40104729
PMCPMC11912037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.